BRIEF-Aveo Oncology Announces Clinical Updates To Tivozanib And Ficlatuzumab Programs By: Reuters: Company News December 07, 2017 at 07:15 AM EST * AVEO ONCOLOGY ANNOUNCES CLINICAL UPDATES TO TIVOZANIB AND FICLATUZUMAB PROGRAMS Read More >> Related Stocks: Aveo Pharmaceuticals